Author Disambiguator

( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)

Potential publications

22 publications found

Click here to create clusters based on exact author strings rather than rougher matches.

Group #1

Check all | Uncheck all

Title	Authors (identified)	Published In	Identifier(s)	Topic	Published Date	Match?
Corrections to Pyridoimidazolones as Novel Potent Inhibitors of v-Raf Murine Sarcoma Viral Oncogene Homologue B1 (BRAF)	[1]Dan Niculescu-Duvaz, [2]Catherine Gaulon, [3]Harmen P. Dijkstra, [4]Ion Niculescu-Duvaz, [5]Alfonso Zambon, [6]Delphine Ménard, [7]Bart M. J. M. Suijkerbuijk, [8]Arnaud Nourry, [9]Lawrence C. Davies, [10]Helen Manne, ..., [14]Steven Whittaker, [15]Ruth Kirk, [16]Adrian Gill, [17]Richard D. Taylor, [18]Florence I. Raynaud, ... [Full author list]	Journal of Medicinal Chemistry [missing]	DOI: 10.1021/JM901076G [ORCID]		2009-09-24
Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ring.	[1]Delphine Ménard, [2]Ion Niculescu-Duvaz, [3]Harmen P Dijkstra, [4]Dan Niculescu-Duvaz, [5]Bart M J M Suijkerbuijk, [6]Alfonso Zambon, [7]Arnaud Nourry, [8]Esteban Roman, [9]Lawrence C. Davies, [10]Helen A Manne, [11]Frank Friedlos, [12]Ruth Kirk, [13]Steven Whittaker, [14]Adrian Gill, [15]Richard D Taylor, [16]Richard Marais, [17]Caroline J Springer [Full author list]	Journal of Medicinal Chemistry [missing]	DOI: 10.1021/JM900242C [ORCID] PubMed: 19473026 [ORCID]		2009-07-01
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF).	[1]Dan Niculescu-Duvaz, [2]Catherine Gaulon, [3]Harmen P Dijkstra, [4]Ion Niculescu-Duvaz, [5]Alfonso Zambon, [6]Delphine Ménard, [7]Bart M J M Suijkerbuijk, [8]Arnaud Nourry, [9]Lawrence C. Davies, [10]Helen Manne, ..., [14]Steven Whittaker, [15]Ruth Kirk, [16]Adrian Gill, [17]Richard D Taylor, [18]Florence Raynaud, ... [Full author list]	Journal of Medicinal Chemistry [missing]	DOI: 10.1021/JM801509W [ORCID] PubMed: 19323560 [ORCID]		2009-04-01

Group #2

Check all | Uncheck all

Title	Authors (identified)	Published In	Identifier(s)	Topic	Published Date	Match?
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS	[1]Christopher J. Schulze, [2]Kyle J. Seamon, [3]Yulei Zhao, [4]Yu Chi Yang, [5]Jim Cregg, [6]Dongsung Kim, [7]Aidan Tomlinson, [8]Tiffany J Choy, [9]Zhican Wang, [10]Ben Sang, ..., [32]Robert Nichols, [33]David Wildes, [34]Adrian L. Gill, [35]Jacqueline A M Smith, [36]Piro Lito [Full author list]	Science [missing]	DOI: 10.1126/SCIENCE.ADG9652 [ORCID]		2023-08-17
Allosteric inhibition of SHP2 stimulates anti-tumor immunity by transforming the immunosuppressive environment	[1]Elsa Quintana, [2]Christopher J Schulze, [3]Darienne R Myers, [4]Tiffany J Choy, [5]Kasia Mordec, [6]David Wildes, [7]Nataliya Tobvis Shifrin, [8]Amira Belwafa, [9]Elena S Koltun, [10]Adrian L Gill, [11]Mallika Singh, [12]Stephen Kelsey, [13]Mark A Goldsmith, [14]Robert Nichols, [15]Jacqueline A M Smith [Full author list]	Cancer Research [missing]	DOI: 10.1158/0008-5472.CAN-19-3038 [ORCID] PubMed: 32350067 [ORCID]		2020-04-29
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers	[1]Robert J Nichols, [2]Franziska Haderk, [3]Carlos Stahlhut, [4]Christopher J Schulze, [5]Golzar Hemmati, [6]David Wildes, [7]Christos Tzitzilonis, [8]Kasia Mordec, [9]Abby Marquez, [10]Jason Romero, ..., [17]Gert Kiss, [18]Elena S Koltun, [19]Adrian L Gill, [20]Mallika Singh, [21]Mark A Goldsmith, ... [Full author list]	Nature Cell Biology [missing]	DOI: 10.1038/S41556-018-0169-1 [ORCID] PubMed: 30104724 [ORCID]		2018-08-13

Group #3

Check all | Uncheck all

Title	Authors (identified)	Published In	Identifier(s)	Topic	Published Date	Match?
Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity	[1]Steven Howard, [2]Valerio Berdini, [3]John A Boulstridge, [4]Maria G Carr, [5]David M Cross, [6]Jayne Curry, [7]Lindsay A Devine, [8]Theresa R Early, [9]Lynsey Fazal, [10]Adrian L Gill, [11]Michelle Heathcote, [12]Sarita Maman, ... [Full author list]	Journal of Medicinal Chemistry [missing]	DOI: 10.1021/JM800984V [ORCID] PubMed: 19143567 [ORCID]		2009-01-01
Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation.	[1]Adrian L Gill, [2]Martyn Frederickson, [3]Anne Cleasby, [4]Steven J Woodhead, [5]Maria G Carr, [6]Andrew J Woodhead, [7]Margaret T Walker, [8]Miles S Congreve, [9]Lindsay A Devine, [10]Dominic Tisi, [11]Marc O'Reilly, [12]Lisa C A Seavers, [13]Deborah J Davis, [14]Jayne Curry, [15]Rachel Anthony, [16]Alessandro Padova, [17]Christopher W Murray, [18]Robin A E Carr, [19]Harren Jhoti [Full author list]	Journal of Medicinal Chemistry [missing]	DOI: 10.1021/JM049575N [ORCID] PubMed: 15658855 [ORCID]	3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE [missing]	2005-01-01

Group #4

Check all | Uncheck all

Title	Authors (identified)	Published In	Identifier(s)	Topic	Published Date	Match?
Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agents	[1]Alleyn T Plowright, [2]Ola Engkvist, [3]Adrian Gill, [4]Laurent Knerr, [5]Qing-Dong Wang [Full author list]	Angewandte Chemie International Edition [missing]	DOI: 10.1002/ANIE.201307034 [ORCID] PubMed: 24470316 [ORCID]	drug discovery [missing]	2014-01-27
What is the most important approach in current drug discovery: doing the right things or doing things right?	[1]Thomas Elebring, [2]Adrian Gill, [3]Alleyn T Plowright [Full author list]	Drug Discovery Today [missing]	DOI: 10.1016/J.DRUDIS.2012.04.009 [ORCID] PubMed: 22569181 [ORCID]	drug discovery [missing]	2012-04-27

Group #5

Check all | Uncheck all

Title	Authors (identified)	Published In	Identifier(s)	Topic	Published Date	Match?
A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hit.	[1]Timothy D Cushing, [2]Vijay Baichwal, [3]Karen Berry, [4]Roland Billedeau, [5]Viola Bordunov, [6]Chris Broka, [7]Mario Cardozo, [8]Peng Cheng, [9]David Clark, [10]Stacie Dalrymple, [11]Michael DeGraffenreid, [12]Adrian Gill, [13]Xiaolin Hao, [14]Ronald C Hawley, ... [Full author list]	Bioorganic & Medicinal Chemistry Letters [missing]	DOI: 10.1016/J.BMCL.2010.10.126 [ORCID] PubMed: 21074993 [ORCID]		2010-10-29
A novel series of IKKβ inhibitors part II: description of a potent and pharmacologically active series of analogs.	[1]Timothy D Cushing, [2]Vijay Baichwal, [3]Karen Berry, [4]Roland Billedeau, [5]Viola Bordunov, [6]Chris Broka, [7]Michelle F Browner, [8]Mario Cardozo, [9]Peng Cheng, [10]David Clark, [11]Stacie Dalrymple, [12]Michael DeGraffenreid, [13]Adrian Gill, [14]Xiaolin Hao, [15]Ronald C Hawley, ... [Full author list]	Bioorganic & Medicinal Chemistry Letters [missing]	DOI: 10.1016/J.BMCL.2010.10.125 [ORCID] PubMed: 21074992 [ORCID]	pharmacology [missing]	2010-10-29

Misc

Check all | Uncheck all

Title	Authors (identified)	Published In	Identifier(s)	Topic	Published Date	Match?
Automated iterative Csp3–C bond formation	[1]Daniel J. Blair, [2]Sriyankari Chitti, [3]Melanie Trobe, [4]David M. Kostyra, [5]Hannah M. S. Haley, [6]Richard L. Hansen, [7]Steve G. Ballmer, [8]Toby J. Woods, [9]Wesley Wang, [10]Vikram Mubayi, [11]Michael J. Schmidt, [12]Robert W. Pipal, [13]Greg. F. Morehouse, [14]Andrea M. E. Palazzolo Ray, [15]Danielle L. Gray, [16]Adrian L. Gill, [17]Martin D. Burke [Full author list]	Nature [missing]	DOI: 10.1038/S41586-022-04491-W [ORCID]		2022-02-08
Structure guided lead generation for M. tuberculosis thymidylate kinase (Mtb TMK): discovery of 3-cyanopyridone and 1,6-naphthyridin-2-one as potent inhibitors	[1]Maruti Naik, [2]Anandkumar Raichurkar, [3]Balachandra S Bandodkar, [4]Begur V Varun, [5]Shantika Bhat, [6]Rajesh Kalkhambkar, [7]Kannan Murugan, [8]Rani Menon, [9]Jyothi Bhat, [10]Beena Paul, ..., [16]Helen McMiken, [17]Swati Prasad, [18]Adrian Gill, [19]Bheemarao G Ugarkar, [20]Janani Venkatraman, ... [Full author list]	Journal of Medicinal Chemistry [missing]	DOI: 10.1021/JM5012947 [ORCID] PubMed: 25486447 [ORCID]	tuberculosis [missing]; Mycobacterium tuberculosis [missing]	2015-01-22
Using matched molecular series as a predictive tool to optimize biological activity	[1]Noel O'Boyle, [2]Jonas Boström, [3]Roger Sayle, [4]Adrian Gill [Full author list]	Journal of Medicinal Chemistry [missing]	DOI: 10.1021/JM500022Q [ORCID] PubMed: 24601597 [ORCID]		2014-03-14
Stapled Vasoactive Intestinal Peptide (VIP) Derivatives Improve VPAC2 Agonism and Glucose-Dependent Insulin Secretion	[1]Fabrizio Giordanetto, [2]Jefferson D Revell, [3]Laurent Knerr, [4]Marie Hostettler, [5]Amalia Paunovic, [6]Claire Priest, [7]Annika Janefeldt, [8]Adrian Gill [Full author list]	ACS Medicinal Chemistry Letters [missing]	DOI: 10.1021/ML400257H [ORCID] PubMed: 24900623 [ORCID]	glucose [missing]; glycobiology [missing]	2013-10-16
Optimisation of pharmacokinetic properties in a neutral series of 11β-HSD1 inhibitors	[1]James S. Scott, [2]Adrian L Gill, [3]Linda Godfrey, [4]Sam D Groombridge, [5]Amanda Rees, [6]John Revill, [7]Paul Schofield, [8]Pernilla Sörme, [9]Andrew Stocker, [10]John G Swales, [11]Paul R O Whittamore [Full author list]	Bioorganic & Medicinal Chemistry Letters [missing]	DOI: 10.1016/J.BMCL.2012.08.070 [ORCID] PubMed: 23013933 [ORCID]	pharmacokinetics [missing]	2012-09-05
Kinetic efficiency: the missing metric for enhancing compound quality?	[1]Geoffrey A Holdgate, [2]Adrian L Gill [Full author list]	Drug Discovery Today [missing]	DOI: 10.1016/J.DRUDIS.2011.09.006 [ORCID] PubMed: 21946261 [ORCID]		2011-09-10
A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development	[1]Adrian L Gill, [2]Marcel Verdonk, [3]Robert G Boyle, [4]Richard Taylor [Full author list]	Current Topics in Medicinal Chemistry [missing]	DOI: 10.2174/156802607781696819 [ORCID] PubMed: 17692029 [ORCID]		2007-01-01
The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallography	[1]Adrian Gill, [2]Anne Cleasby, [3]Harren Jhoti [Full author list]	ChemBioChem [missing]	DOI: 10.1002/CBIC.200400188 [ORCID] PubMed: 15696598 [ORCID]	X-ray crystallography [missing]	2005-03-01
New lead generation strategies for protein kinase inhibitors - fragment based screening approaches	[1]Adrian Gill [Full author list]	Mini-Reviews in Medicinal Chemistry [missing]	DOI: 10.2174/1389557043487385 [ORCID] PubMed: 15032676 [ORCID]		2004-03-01
Protein kinases in drug discovery and development.	[1]Adrian Gill [Full author list]	Drug Discovery Today [missing]	DOI: 10.1016/S1359-6446(04)02932-0 [ORCID] PubMed: 14761801 [ORCID]	drug discovery [missing]	2004-01-01

Potential author items

	Name	Description	Authored items	Identifiers	Employer(s)
	A. A. Gill	British writer and critic (1954–2016)	0	ISNI: 0000000109622613 VIAF ID: 28804003	Slade School of Fine Art [missing] St Christopher School [missing]
	Adrian Gill	Australian meteorologist (1937-1986)	0	ISNI: 000000008167631X VIAF ID: 94855993	University of Cambridge [missing]
	Adrian Gill	US professional association football player	0
		Other Q number of this author

New Author Item

(if the author you are looking for is not listed above and otherwise not yet in Wikidata)

After creating the new author item, enter the Wikidata ID in the "Other Q number of this author" field above to link to their works.

Author items in these papers

Common author name strings in these papers

Publishing venues for these papers

Topics for these papers

Feedback
Source and documentation (at github)
Wikidata page